Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
08/2010
08/19/2010US20100210833 Method of producing nucleosides
08/19/2010US20100210581 Nucleoside Derivatives as Inhibitors of Viral Polymerases
08/19/2010CA2751277A1 Carba-nucleoside analogs for antiviral treatment
08/18/2010EP2217612A1 Preparation of nucleotide oligomer
08/18/2010EP2217611A1 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
08/18/2010EP2217247A1 Novel synthesis of beta-nucleosides
08/18/2010EP1261616B1 Modified oligonucleotides for mismatch discrimination
08/17/2010US7777024 Process for preparing a pentopyranosyl nucleic acid conjugate
08/17/2010US7777023 efficient solid phase synthesis using a dimethoxytrityl (DMT) protected nucleoside succinate such as 5'-O-DMT-3'-O-succinyl uridine linked to a solid support such as controlled pore glass
08/17/2010US7777013 A nucleoside coupled to a chain of 4-6 phosphate and linked distantly to nonhydrolysing groups and a label for greater stability and processibility when incorporated by polymerase into growing polynucleotide strands in a template dependent synthesis; biosynthesis; DNA sequencing; hybridization assays
08/17/2010US7776838 such as AZT; derivatives of uridine or cytidine such as triacetyluridine and ethoxycarbonyluridine or triacetylcytidine, capable of attenuating damage to hematopoietic system in animals; interleukins; colony stimulating factors
08/17/2010US7776568 Methods and kits using extended rhodamine dyes
08/17/2010US7776567 performing a nucleic acid amplification reaction by providing a reaction mixture comprising the target nucleic acid, reagents necessary for amplifying the target, and a fluorescent nucleic acid dye; used in DNA quantitation in real-time PCR
08/17/2010US7776536 Determining relative copy number of oncogenenucleotide sequences and precise mapping of chromosomal abnormalities associated with preferential cancers; diagnosing cell proliferative disorders
08/17/2010CA2450637C Solid-phase nucleophilic fluorination
08/12/2010WO2010090969A1 Tetrahydropyran nucleic acid analogs
08/12/2010WO2010003540A3 A method for the formation of megamitochondria
08/12/2010US20100204463 Preparation Of Synthetic Nucleosides via Pi-Allyl Transition Metal Complex Formation
08/12/2010US20100204172 Inactivators of o6-alkylguanine-dna alkyltransferase
08/12/2010US20100203541 Nucleotide analogs
08/11/2010EP2216414A1 Cell-free translation system
08/11/2010EP2216338A1 Light-responsive artificial nucleotide having photo-crosslinking ability
08/11/2010CN1972696B Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
08/11/2010CN101798330A Extraction and purification method of pentostatin
08/10/2010US7772384 nucleotides having a removable labels, used in polynucleotide sequencing
08/10/2010US7772383 Chemical PCR: Compositions for enhancing polynucleotide amplification reactions
08/10/2010US7772208 Hepatitis C virus infections; beta -L-2',3'-dideoxy-5-fluorocytidine
08/10/2010US7772207 Combination of a CDK inhibitor and CS-682 or a metabolite thereof
08/10/2010US7772199 Forms of 5-azacytidine
08/10/2010US7772198 cycstic fibrosis transmembrane conductance regulators (CFTR); for treatment of cystic fibrosis, asthma or diarrhea
08/10/2010US7772197 nucleoside or nucleotide analogues; RNA viral diseases
08/10/2010US7771973 Modified nucleotides
08/10/2010US7771945 Apparatus and method for preparative scale purification of nucleic acids
08/05/2010US20100197627 Pancreatic cancer treatment
08/05/2010US20100196988 Bioreactive Agents
08/05/2010US20100196273 Novel agent for in vivo pet imaging of tumor proliferation
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010CN101796062A 6-disubstituted bicyclic nucleic acid analogs
08/04/2010CN101792788A Preparation method of 5'-acylated cytidine and application in preparing medicaments for treating heart and liver diseases
08/04/2010CN101792475A CDP-2-glycerol synthesized in gram-positive bacteria and preparation method thereof
08/04/2010CN101792474A Novel AzalomycinF microlide compounds and preparation method thereof and application thereof
08/04/2010CN101016319B Benzoisoselenothiazolidone aminosugar derivative, preparing method and application therheof
08/03/2010US7767805 Methods and compositions for sequencing a nucleic acid
08/03/2010CA2490191C Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections
07/2010
07/29/2010US20100190972 Heteropolynucleotide Duplexes With Purine-Purine Base Pairing
07/29/2010US20100190837 5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
07/29/2010CA2749055A1 Antiviral agents
07/28/2010EP2210896A1 Process for production of ribofuranose derivatives
07/28/2010EP2209911A1 Dna sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
07/28/2010CN101787066A Cytarabine prodrug derivatives and purposes thereof in resisting cancers and tumors
07/28/2010CN101787065A Cytarabine prodrug derivatives and purposes thereof in resisting cancers and tumors
07/28/2010CN101787064A Cytarabine prodrug derivatives and purposes thereof in resisting cancers and tumors
07/28/2010CN101787046A Preparation method of intermediate compound of Decitabine
07/27/2010US7763465 Unique novel Bacillus thuringiensis gene with lepidopteran activity
07/22/2010WO2010082128A1 Process for the preparation of cis-nucleoside derivative
07/22/2010US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells
07/22/2010US20100184715 Stable salts of s-adenosylmethionine and process for the preparation thereof
07/22/2010US20100184074 Universal nucleotides for nucleic acid analysis
07/21/2010EP2207900A1 Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis
07/21/2010EP2207786A1 2 ' -flu0r0-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors
07/21/2010CN101784557A Azido purine nucleosides for treatment of viral infections
07/21/2010CN101784556A thiocarbon-protecting groups for rna synthesis
07/21/2010CN101781348A Stable protein kinase activator, preparation method thereof and use
07/21/2010CN101781347A Polymorphic substances of decitabine and medical compositions
07/21/2010CN101781346A Method for separating uridylic acid from biocatalytic conversion solution
07/20/2010US7759513 Photolabile protective groups for improved processes to prepare oligonucleotide arrays
07/20/2010US7759481 4-amino-1- beta -D-ribofuranosyl-1,3,5-triazin-2(1H)-one containing about 10 ppm to about 2000 ppm of non-volatile solvents; antineoplastic drug exhibiting activity against, e.g., leukemia, lymphoma and various solid tumours
07/20/2010US7759471 Monomer compositions for the synthesis of RNA, methods of synthesis, and methods of deprotection
07/20/2010US7759470 Labeling reagent
07/20/2010US7759322 Method of treating dry eye disease with purinergic receptor agonists
07/20/2010US7759321 Administering a side-effect-avoiding dosage of a 1-alkoxyadenosine, excluding 2-methoxyadenosin; treating neuropathic pain and pain caused associated with inflammation or tissue damage
07/20/2010US7759061 2′-nitrobenzyl-modified ribonucleotides
07/20/2010CA2340931C 3'-deoxypentopyranosylnucleic acid, its preparation and use
07/20/2010CA2322487C Novel prodrugs for phosphorus-containing compounds
07/20/2010CA2266908C O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
07/15/2010WO2010081082A2 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
07/15/2010WO2010079813A1 Method for manufacturing inosine derivative
07/15/2010US20100179314 Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof
07/15/2010US20100179313 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
07/15/2010US20100179312 Convertible nucleoside derivatives
07/15/2010US20100179101 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound
07/15/2010CA2749394A1 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
07/14/2010EP2205073A1 Azacytidine analogues and uses thereof
07/14/2010CN101778859A Improved process for the production of nucleotide sugars
07/14/2010CN101775052A Preparation method for partial and full agonists of a1 adenosine receptors
07/13/2010US7754699 Propionic Acid (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-hydroxy-4-methyl-3-propionyloxy-tetrahydro-furan-2-ylmethyl ester; inhibit RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase
07/08/2010WO2010077578A1 Bis-modified bicyclic nucleic acid analogs
07/08/2010US20100174059 Process for the production of nucleotide sugars
07/08/2010US20100174058 Fluorescent quenching detecting reagents and methods
07/08/2010US20100173870 Phosphonate Compounds
07/08/2010US20100173863 2-Fluoronucleosides
07/07/2010EP2203463A2 Antiviral agents
07/07/2010CN101768197A Preparation method for nelarabine
07/07/2010CN101768196A Synthesizing process of capecitabine
07/07/2010CN101768195A Iodinated linoleic acid deoxidation fluorouracil glucoside ester, preparation method and application thereof
07/06/2010US7751982 TM leveling methods
07/06/2010US7750153 crystalline alkali metal or alkaline earth metal salt of 2',3'-dideoxy-2',3'-didehydroinosine; catalytic hydrogenation and then neutralized with hydrochloric acid
07/06/2010US7750131 (1R,3R,4R,7S)-7-[2-Cyanoethoxy(diisopropylamino)phosphinoxy]-1-[1-(S)-(4,4'-dimethoxytrityl)oxy-ethyl]-3-(uracil-1-yl)-2,5-dioxa-bicyclo[2.2.1]heptane; useful for enhancing properties of oligomeric compounds including nuclease resistance
07/01/2010WO2010075554A1 Synthesis of purine nucleosides
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 201